Progress of Federal Lipitor Lawsuits to Be Addressed During May Case Management Conference

New York, New York (PRWEB) May 17, 2015

The federal court overseeing thousands of Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) will convene its next Case Management Conference on Thursday, March 21, 2015 at 10:00 a.m. According to a Joint Status Report filed with the U.S. District Court, District of South Carolina on May 14, 2015, the Conference will address a number of issues, including the status of document production by Pfizer, Inc. and discovery in bellwether cases. The Court will also receive updates regarding federal Lipitor lawsuits that have not yet been transferred to the multidistrict litigation, and the status of related claims pending in various state courts. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

"Monthly case management conferences are intended to ensure that large, complex litigations are progressing as efficiently as possible. Our Firm is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation, and the issues to be addressed at this month's conference will likely prove relevant to our clients," Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to provide free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Litigation
Court documents indicate that more than 2,000 Lipitor lawsuits have been filed in the federal multidistrict litigation on behalf of plaintiffs who allege the medication increases the risk that a patient will develop Type 2 diabetes. The litigation has been growing since February 2012, when the U.S. Food & Drug Administration ordered Pfizer, Inc. and other statin manufacturers to add new information to their product labels regarding their potential impact on blood glucose levels. The FDA acted after a study published the previous month in JAMA: Internal Medicine suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes.*

According to court records, all of the claims allege that Pfizer Inc. was aware of the link between Lipitor and diabetes before modifying the drug's label in February 2012, but concealed this information in order to protect sales of the medication. The lawsuits further allege that the label modifications made by Pfizer in 2012 still do not adequately address this risk.

Lipitor patients who allegedly developed Type 2 diabetes due to their use of the statin medication may be entitled to compensation. To learn more about the federal Lipitor litigation, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to obtain a free legal review.

*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.lipitorlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12727512.htm

You May Also Be Interested In

• Singtel Partners with Vonage to Accelerate Global Enterprise and Telco Innovation and Digital Transformation
• NOTICE TO THE ANNUAL GENERAL MEETING OF QPR SOFTWARE PLC
• ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024